- Book
- November 2019
United States
- Book
- May 2021
- 576 Pages
- Book
- March 2016
- 544 Pages
- Book
- May 2014
- 224 Pages
- Book
- April 2011
- 478 Pages
- Book
- April 2009
- 514 Pages
- Book
- August 2020
Asia Pacific

The Human Diseases market is a subset of the Biology and Life Sciences industry that focuses on the diagnosis, treatment, and prevention of diseases in humans. It includes research and development of drugs, medical devices, and diagnostics, as well as the delivery of healthcare services. This market is driven by advances in medical technology, the emergence of new diseases, and the need for better treatments. It is also influenced by the availability of healthcare resources, the cost of treatments, and the changing demographics of the population.
The Human Diseases market is highly competitive, with a range of players from large pharmaceutical companies to small biotechnology firms. Companies in this market include Pfizer, Merck, Novartis, Johnson & Johnson, Roche, Sanofi, AstraZeneca, GlaxoSmithKline, AbbVie, and Bristol-Myers Squibb. Show Less Read more